Skip to main content

Animations

MJFF Publications

3341 - 3350 of 6324 Results
Title
Year
  • Year
  • 2020
  • 2019
  • 2018
  • 2017
  • 2025
  • 2024
  • 2020
  • 2020
  • 2015
  • 2024
  • Summary Details
    OPEN
    Title: Is Levodopa Response a Valid Indicator of Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28406
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Predictive model of spread of Parkinson's pathology using network diffusion
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2019.03.001
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1948-2
    Citation Count: 144
  • Summary Details
    OPEN
    Title: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41591-025-03831-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Fast, multicolour optical sectioning over extended fields of view with patterned illumination and machine learning
    Journal Name: Biomedical Optics Express
    Publisher: Optica Publishing Group
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1364/boe.510912
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28144
    Citation Count: 31
  • Summary Details
    OPEN
    Title: New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders
    Journal Name: Current Behavioral Neuroscience Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s40473-020-00221-6
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Constructing de Novo H2O2 Signaling via Induced Protein Proximity
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.5b00170
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathway
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-024-02810-1
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.